Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

General Information

Cogstate Limited
Health Care Technology

Current Price Data+

Current Price Open High Low Last Close Volume Price Movement
$0.25 $0.26 $0.26 $0.25 $0.26 34500 $0.01 ( 3.85% )
  • +Security prices are delayed by least 20 minutes and are indicative only.

Company Overview

Business Description
Cogstate Ltd (CGS) is a multi-faceted cognitive assessment and training company focused on the development and commercialisation of rapid, computerised tests of cognition (brain function). The Company has four distinct business units, being Cognitive testing , Sport market , Primary care physician market, Precision recruitment market: and Cogstate Research with 5 primary offices in Australia, USA and Spain.
Strategy Analysis

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014 A -3.9 -4.3 0.0% 0.0 0.0 0.0% 0.0%
2013 A -2.0 -2.6 0.0% 0.0 0.0 0.0% 0.0%
2012 A 2.5 3.3 0.0% 6.8 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Cogstate (CGS) $24M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.98 0.00
Market 0.96 13.30 1.04 0.48
Sector 0.62 24.20 2.82 0.95


Name Position Start Date
Mr Martyn Kenneth Myer Chairman 01/10/1999
Mr Bradley O'Connor Chief Executive Officer 01/12/2005
Dr Alan Finkel Non-Executive Director 12/05/2015
Mr David Alexander Simpson Non-Executive Director 24/08/2004
Mr Richard van den Broek Non-Executive Director 26/08/2010
Mr David Dolby Non-Executive Director 22/11/2013


Name Position
Paul Maruff Chief Scientific Officer
Claire Newstead-Sinclair Company Secretary
Jason Sada President Axon Sports
Sophie Egholm President Clinical Trials

Substantial Shareholders

Holding Name
17,730,714 (17.92%) National Nominees Limited
13,606,389 (13.75%) The Degmar Dolby
12,961,831 (13.10%) Quixote Investment, LLC
7,939,986 (8.02%) Asia Union Investments Pty Ltd

Calendar of Events

Date Event
17 February 2016 Report (Interim)
18 September 2015 Report (Annual)
19 August 2015 Report (Annual)
19 August 2015 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.